Blood centers, corporations and foundations partner with the National Blood Foundation (NBF) to advance and sustain research initiatives that are critical to patient and donor safety in transfusion medicine and cellular therapies. A partnership with the NBF puts your organization at the table with clinical and research leaders similarly dedicated to providing support for innovative, early-stage research that will impact the future of the fields.
Terumo BCT is proud to have provided more than $1 million in support to the NBF. This has helped fund dozens of young scientists and physicians and advance research that is critical to moving our industry forward.”
[David Perez, Former CEO, Terumo BCT]
“Fresenius Kabi is honored to support NBF as a CORD donor for more than 10 years. We remain committed to this partnership and our motivation is to support and recognize the continued advancement of science in support of transfusion medicine,
technologies and cellular therapies.”
[Dean Gregory, President, Medical Devices, Fresenius Kabi]
Vitalant believes it’s critically important to continually further the advancement of transfusion medicine and cellular therapies, in direct alignment with the NBF’s purpose. We’re all in this together – driving for better
patient outcomes and a sustained blood supply.”
[David R. Green, President and CEO, Vitalant]
The Council on Research and Development (CORD), comprised of major contributors, supports the mission of NBF and offers both financial and intellectual support to strategically drive the foundation’s activities to further advance the field. This
exclusive circle of donors also engages in critical conversations among industry manufacturers, providers and patient advocates to shape the future of transfusion medicine and cellular therapies.
The CORD donor program established in 1988, includes leaders of major health care corporations and blood centers who are dedicated to supporting the programs of the National Blood Foundation (NBF). CORD members currently contribute $75,000 annually to the National Blood Foundation Research and Education Trust Fund (NBFRET) which funds the grants programs.
The National Blood Foundation Partners commit both financially and intellectually to support the work of NBF. The Partner donor program was established in 2003 to provide corporate leaders, blood center CEOs and other industry executives with an exclusive opportunity to share information, create relationships and partnerships, and learn first-hand about the current issues critical to the transfusion medicine and cellular therapies from experts in the field. Partners currently contribute $5,000 to $25,000 annually based on their actual gross corporate sales or center revenue.
|Benefit||CORD-Level ($75,000)||Partner-Level ($7,500-$25,000)|
|NBF Board Representation||X 3||X 1|
|Council on Research and Development||•||•|
|Strategic Programming Committee||•||•|
|NBF Website Recognition||•||•|
|Free Access to NBF VIP Industry Events||•||•|
|Two invitations to AABB President’s Reception||•||•|
|Recognition in TRANSFUSION Journal||•||•|
|Special Meeting Badge Ribbons||•||•|
|Recognition at AABB’s Annual Meeting||•||•|
|AABB News “Shaping the Industry Spotlight”||•|
|NBF Website Recognition with Link to Organization Website||•|
For more information about how your organization can partner with the NBF, call +1.301.215.6551 or email firstname.lastname@example.org.
In 2003, the NBF Leadership Forum was designed to provide an exclusive venue for blood center CEOs, medical directors, transfusion medicine physicians and researchers, corporate executives and industry experts to discuss the key issues facing the field.
Today, it is an excellent opportunity for attendees to collaborate with one another, and to share new solutions impacting the transfusion medicine and cellular therapies field. Our goal each year is to continue to advance the dialogue and discussions
among this prestigious group of attendees.
Opportunities to sponsor the Run for Research, the Grant Recipients' Lecture and Luncheon, the NBF Reception and special displays like the NBF Hall of Fame are available to enhance visibility for your organization and to show your employees, colleagues and customers your support for the vital NBF mission to fuel innovation in transfusion medicine and cellular therapies to benefit patients and donors. Contact the NBF at email@example.com for details.
Foundations with like-minded goals to those of the National Blood Foundation support the work of NBFRET through grants. Currently a number of community health foundations are funding research and education in blood banking and transfusion medicine through NBF. With a mutual interest in providing quality health care to all individuals worldwide, foundations and NBF can build close working partnerships to help solve some of the most important health concerns of today.
The Santa Barbara Foundation
The Topeka Community Foundation
Individuals often make donations to NBF to support its work, as well as to honor or in memory of someone. AABB members, families, co-workers, and friends who want to encourage scientific research or have experienced the value of maintaining an adequate and safe supply of blood are encouraged to recognize someone through a contribution to NBF. To donate please follow this link.
Throughout the years, major corporations, blood centers, and individuals have chosen to make grants to the NBF to establish an annual award or prize in honor of an individual who they believe was or is a leader in the field of transfusion medicine or blood banking.
For information about making an unrestricted or restricted grant, memorial award, or contribution, contact the office of the National Blood Foundation +1.301.215.6552 or by email -- firstname.lastname@example.org
Your charitable gift planning, that includes the National Blood Foundation, can be of great benefit to all concerned. Such gifts enable NBF to strengthen its giving program for the future. Because tax and other financial consequences of each plan vary,
you and your financial advisor can only make the best choice after careful consideration.
December 02, 2020
November 30, 2020
November 13, 2020